Last Update 02 Nov 25
Fair value Decreased 2.09%Colgate-Palmolive’s fair value estimate has been reduced from $90.74 to $88.84 per share. Analysts cite persistent category headwinds and a moderated sales outlook as factors behind lower price targets across the sector.
Analyst Commentary
Recent analyst research on Colgate-Palmolive reflects a mixed outlook for the company's shares, with adjustments to price targets and ratings highlighting both strengths and concerns around valuation, growth, and sector trends.
Bullish Takeaways
- Bullish analysts continue to maintain positive ratings. They cite Colgate-Palmolive's durable brand equity and strategic footprint, particularly in key international markets such as Latin America.
- Recent quarterly results were generally in line with expectations. This supports the view that operational discipline remains a core strength for the company.
- The new 2030 Strategic Plan, which includes a multiyear restructuring to optimize the supply chain and streamline operations, is seen as a driver for future margin improvement and long-term value creation.
- Despite near-term challenges, the company's commitment to targeted growth initiatives and ongoing cost optimization efforts is expected to support resilient execution in evolving market conditions.
Bearish Takeaways
- Bearish analysts point to ongoing category headwinds that are likely to impact top-line growth over the near term, resulting in several downward adjustments to price targets.
- Muted and decelerating growth in parts of the personal care sector and softening consumer demand may weigh on both sales and earnings expectations.
- Management's reduced sales guidance to the lower end of the prior range reflects a more cautious revenue outlook.
- Most recent research calls for moderated growth and flat margin progression. These factors keep some analysts on the sidelines with Neutral or equivalent recommendations.
What's in the News
- Colgate-Palmolive updated its 2025 earnings guidance and projects net sales to increase by low single digits, with a flat to low-single-digit negative impact from foreign exchange. (Company guidance)
- The company now expects organic sales growth of 1% to 2% for 2025, which is a reduction from the earlier 2% to 4% range. (Company guidance)
- The lowered sales forecast reflects an estimated 70 basis point impact from Colgate-Palmolive's exit from private label pet sales. This aligns with the year-to-date organic sales growth of 1.2%. (Company guidance)
Valuation Changes
- The Fair Value Estimate has decreased slightly from $90.74 to $88.84 per share, reflecting ongoing industry and company-specific pressures.
- The Discount Rate remains unchanged at 6.78%.
- The Revenue Growth projection has been reduced marginally from 3.43% to 3.33%.
- The Net Profit Margin forecast has risen slightly from 15.68% to 15.75%.
- The Future Price/Earnings (P/E) ratio has declined from 24.89x to 23.98x, suggesting a lower market valuation of future earnings.
Key Takeaways
- Expansion in oral care and focus on emerging markets, with premiumization and innovation, drive sustained volume growth and strengthen global brand positioning.
- Investment in AI, digital transformation, and productivity boosts efficiencies, enabling reinvestment into growth and supporting stable margins and resilience against market cycles.
- Persistent cost pressures, cautious consumer behavior, and competitive challenges in major markets are constraining margin expansion, topline growth, and long-term revenue prospects.
Catalysts
About Colgate-Palmolive- Manufactures and sells consumer products in the United States and internationally.
- Expansion and premiumization of core oral care lines like Colgate Total, coupled with the roll-out of complementary products across 75 markets, are set to capture increased value from emerging middle-class consumers and rising health/hygiene awareness globally-supporting top-line organic sales acceleration and improved pricing power.
- Emerging markets such as India, Latin America, and Southeast Asia-where rising incomes and urbanization are growing the addressable customer base-remain a strategic focus with stepped-up innovation, brand investment, and price tiering, sustaining long-term volume and revenue growth.
- Continued investments in AI, digital transformation, and omnichannel demand generation are expected to enhance operational efficiency, customer reach, and data-driven marketing, translating into greater sales effectiveness and margin resilience.
- Productivity and restructuring initiatives ($200–$300 million over three years) are designed to free up resources for innovation, digital, and R&D investments, enabling incremental margin expansion and additional reinvestment for growth.
- Category stabilization and long-term brand strength, particularly in daily-use, trusted segments (oral care, pet nutrition), position Colgate-Palmolive to outperform peers as consumer confidence rebounds, supporting consistent earnings growth and de-risking revenue from cyclical downturns.
Colgate-Palmolive Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?- Analysts are assuming Colgate-Palmolive's revenue will grow by 3.8% annually over the next 3 years.
- Analysts assume that profit margins will increase from 14.5% today to 15.5% in 3 years time.
- Analysts expect earnings to reach $3.5 billion (and earnings per share of $4.43) by about September 2028, up from $2.9 billion today.
- In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 26.1x on those 2028 earnings, up from 23.4x today. This future PE is greater than the current PE for the US Household Products industry at 21.6x.
- Analysts expect the number of shares outstanding to decline by 1.08% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 6.78%, as per the Simply Wall St company report.
Colgate-Palmolive Future Earnings Per Share Growth
Risks
What could happen that would invalidate this narrative?- Consumer caution and category softness in key markets like North America, Brazil, and India could persist due to elevated food inflation and macroeconomic uncertainty, potentially constraining volume growth and revenue.
- Rising raw material and packaging costs, particularly for palm oil and fats, are significantly impacting gross margin, and relief is uncertain, posing ongoing pressure on net margins and profitability.
- Increased focus on price pack architecture and value offerings in response to cautious consumers and lower category inflation may limit the company's ability to drive premium pricing, potentially compressing margins and slowing topline growth.
- Company performance in China and India is being challenged by local market dynamics, with China's Hawley & Hazel business requiring significant repositioning in a highly competitive e-commerce environment and India experiencing urban market sluggishness, both of which could hinder long-term revenue growth in these important markets.
- Continued exposure to private label competition, especially in the pet food category and key emerging markets, along with the exit from private label production, could negatively impact reported sales growth and overall earnings during the transition period.
Valuation
How have all the factors above been brought together to estimate a fair value?- The analysts have a consensus price target of $95.222 for Colgate-Palmolive based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $106.0, and the most bearish reporting a price target of just $83.0.
- In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $22.4 billion, earnings will come to $3.5 billion, and it would be trading on a PE ratio of 26.1x, assuming you use a discount rate of 6.8%.
- Given the current share price of $84.28, the analyst price target of $95.22 is 11.5% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
How well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

